STAT5B and breast carcinoma: In preclinical studies using mouse models and in correlative studies using human DCISs and tumor-adjacent epithelia, we have found that STAT5 suppresses apoptosis in mammary early lesions, promotes progression to cancer, and may be a valuable target for chemoprevention in women with increased risk of breast cancer [24].